中国制药企业的追赶:技术复杂性与部门创新  

A Study on the Catch-up Strategy of Chinese Pharmaceutical Firms:Technical Complexity and Sectoral Innovation

作　　者：张黎明[1] 胡豪[2] 石韵臻[2] 

机构地区：[1]四川大学商学院,四川成都610064 [2]澳门大学中华医药研究院,澳门999078

出　　处：《四川大学学报（哲学社会科学版）》2013年第6期98-107,共10页Journal of Sichuan University：Philosophy and Social Science Edition

基　　金：国家自然科学基金项目"竞争性制度逻辑条件下公司品牌化的战略选择研究"(71240012);四川大学中央高校基本科研业务费研究专项项目资助"不确定条件下公司品牌与战略选择的关系研究"(skqy201209);澳门大学RC项目"Universities and Contract Research Organizations as Actors of Regional;Sectoral Innovation System in Emerging Bioscience Clusters and TCM Science Park:Driver;Configuration;&Innovation"(MYRG160(Y1-L2)-ICMS11-HH)

摘　　要：中国制药产业的追赶代表着中国在诸多系统复杂性产业的发展未来。部分领先制药企业的实践表明,中国制药产业无法采取跨越式的追赶,因为首要的制约因素是技术的系统复杂性,当然制度和知识输入的不足也发挥着显著的影响。中国制药产业的追赶需要建立适合自身的部门创新系统,以自身的技术能力培养来确立未来产业竞争的基础。The catch-up of Chinese pharmaceutical industry represents the future of many industries characterized by technical complexity in China. The practice of some leading pharmaceutical companies in China indicates that Chinese pharmaceutical finns can＇t adopt leapfrog development because of the primary constraint and the systematical complexity in technology. Besides, the weakness in institution and knowledge input also play influential roles. The catch-up of Chinese pharmaceutical industry consists in specific sectoral innovation through which the foundation for future industrial competition is guaranteed by cultivating its own technical capability.

关 键 词：追赶战略 技术复杂性 部门创新 技术跨越 技术能力 网络能力 

分 类 号：F273.1[经济管理—企业管理]